• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Telehealth Giant Teladoc Files for IPO

by HITC Staff 04/30/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Telehealth Provider Teladoc

On late Tuesday this week, Dallas-based telehealth provider, Teladoc filed a confidential draft registration form for an initial public offering (IPO) to the U.S. Securities and Exchange Commission (SEC), WSJ reports. Founded in 2002, the company emerged as an early leader in the growing telehealth space as self-insured employers and insurance companies look for ways to cut healthcare costs by providing a video visits platform for doctors and patients.

The company has raised more than $100 million in funding with a valuation of more than $300 million backed by Jafco Ventures, Greenspring Associates, the Mellon Family Foundation, QuestMark Partners, FLAG Capital Management LLC, Cardinal Partners, HLM Venture Partners, Kleiner Perkins Caufield & Byers, New Capital Partners and Trident Capital.

The number of shares of common stock to be sold and the price range for the proposed offering have not yet been determined, the statement said. 

Teladoc moves to block Texas Medical Board rule

Additionally, Teladoc has filed an antitrust lawsuit in the U.S. District Court for the Western District of Texas against the Texas Medical Board and its members to prevent a new rule from taking effect that would restrict the practice of telehealth.

Teladoc’s case asserts that the medical board, charged with regulating medical practice in Texas, is in fact illegally limiting competition by requiring an in-person visit before physicians are allowed to treat patients. Texas physicians have treated patients with no prior in-person contact for decades.

The new rule is scheduled to take effect in June. If enacted as written, the rule may have severe financial consequences for telehealth companies as well as patients, according to the Teladoc lawsuit.

The Teladoc lawsuit also notes that the Texas Medical Board ignored hundreds of officially filed comments from consumers, physicians, and businesses opposing the new rule and supporting both the efficacy and the safety of telehealth. Teladoc reports 95 percent customer satisfaction and 92 percent patient medical issue resolution. Teladoc physicians are board-certified, state-licensed and average 20 years of experience. Teladoc is certified by the National Committee for Quality Assurance and has operated in Texas for more than 10 years with a strong patient safety record devoid of even a single malpractice claim.

During the last four years, as the Texas Medical Board sought to limit access to health care in the state, Texas courts have ruled in favor of Teladoc on five separate occasions. “Our attention and commitment to safety, while delivering significant value, leaves us confident that the courts will again rule in favor of enhanced access to affordable, quality health care over the narrow concerns of a special interest intent on protecting itself to the detriment of patients,” said Teladoc CEO Jason Gorevic.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |